Contineum Therapeutics, Inc. · NASDAQ:CTNM

Stengone Carmine N. sold 10,000 Contineum Therapeutics, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Stengone Carmine N. (Director, CEO and President) sold 10,000 Contineum Therapeutics, Inc. shares at US$16.01 for US$160K under a trading plan, leaving 17,217 shares. Filed Jul 1, 2026 (Form 4).

Sold
10,000 shares
Price
US$16.01
Value
US$160K
Holding after
17,217 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO and President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Class A Common StockOption exercise7,500US$1.0124,717Direct
Jun 30, 2026Class A Common StockOption exercise2,500US$1.2627,217Direct
Jun 30, 2026Class A Common StockSale10,000US$16.0117,217Direct

Source

View original at SEC

Related